GBI Research Market Research Reports

Title published price

Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors

By GBI Research

Summary Oncology comprises a large and diverse group of indications, encompassing virtually all sites and tissues in the human body. The diseases are characterized by abnormal cell proliferation, which is followed by local ...

13-Jul-2017 $4995

Pain Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the pain pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Osteoarth ...

01-Jul-2017 $3995

Skeletal Disease Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development f ...

01-Jul-2017 $3995

Transplantation Drug Development Pipeline Review, 2017

By GBI Research

Summary This report provides an overview of the transplantation pipeline landscape, specifically covering drugs used to prevent and treat organ rejection and graft-versus-host disease. The report provides comprehensive inf ...

01-Jul-2017 $3995

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

By GBI Research

Summary Pain can be classified into three main categories. Nociceptive pain involves the activation of nociceptors - neurons specialized in transmitting information regarding pain that signal to the central nervous system ...

01-Jun-2017 $4995

Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation

By GBI Research

Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 distinct dermatological conditions are thought to exist, ranging from rare autoimmune disorders such as ...

01-Jun-2017 $6995

Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

By GBI Research

Asthma is a common chronic inflammatory disease of the airways. It is characterized by recurrent attacks of breathlessness and wheezing that vary in frequency and severity from patient to patient. Variable degrees of airflow obstruction, bronchial ...

01-Jun-2017 $4995

Renal Cluster Drug Development Pipeline Review, 2017

By GBI Research

Renal Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key play ...

11-May-2017 $3995

Women's Health Cluster Drug Development Pipeline Review, 2017

By GBI Research

Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women's health pipeline landscape. The report provides comprehensive information on the therapeutics under development an ...

10-May-2017 $3995

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017

By GBI Research

Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017 Summary This report provides an overview of the toxicology pipeline landscape. The report provides comprehensive information on the therapeutic ...

09-May-2017 $3995

CNS Cluster Addiction Drug Development Pipeline Review, 2017

By GBI Research

CNS Cluster Addiction Drug Development Pipeline Review, 2017 Summary This report provides an overview of the CNS Clusters pipeline landscape. The report provides comprehensive information on the therapeutics under development, and ...

08-May-2017 $3995

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017

By GBI Research

Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017 Summary This report provides an overview of the genetic disorders pipeline landscape. The report provides comprehensive information on the therapeut ...

08-May-2017 $3995

Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

By GBI Research

Summary Hematological cancer describes a group of malignancies that affect the blood, lymph nodes and bone marrow. The three main types are leukemia, lymphoma and myeloma. The American Cancer Society (ACS) predicts that in ...

03-May-2017 $6995

Frontier Pharma: Alzheimer’s Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

By GBI Research

Summary Alzheimer’s disease (AD) is the most common form of dementia - a generalized term used to describe loss of memory and other mental abilities that are severe enough to interfere with daily activities. Symptoms ...

01-May-2017 $6995

Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth

By GBI Research

Summary Immune-mediated inflammatory diseases are a common set of chronic disorders that affect 5-7% of people in Western populations. Although they are often disparate in terms of their symptoms and key patient demographi ...

01-May-2017 $4995

Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs

By GBI Research

Rheumatoid arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects the joints. It is characterized by synovial inflammation and gradual bone erosion over many years (Lefèvre et al., 2009). ...

01-Apr-2017 $4995

Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market

By GBI Research

Breast cancer is a malignant neoplasm that begins in the breast tissue, which is made up of glands for milk production called lobules and the ducts that connect the lobules to the nipples. Most breast cancers are invasive cancers that have grown b ...

01-Apr-2017 $4995

Antibacterial Therapies Drug Development Pipeline Review, 2017

By GBI Research

The antibacterial drug market covers the drugs used in the prophylaxis and treatment of bacterial infections. With a growing global concern over antimicrobial resistance and its progressive growth, there is a pronounced need for innovation within ...

22-Mar-2017 $3995

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

By GBI Research

Neurodegenerative disorders are a cluster of conditions that affect the central nervous system. They include both hereditary and sporadic conditions that are characterized by slow, irreversible, progressive dysfunction of the nervous system with t ...

21-Mar-2017 $3995

Cardiovascular Disorders Drug Development Pipeline Review, 2017

By GBI Research

Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia of which accelerate the development of atherosclero ...

16-Mar-2017 $3995